DENTERIC

Denteric is developing therapies for Porphyromonas gingivalis (Pg) related diseases - initially focused on severe periodontal disease... Our first product is a therapy designed to neutralise virulence factors (toxins) circulating in the blood that are produced by Pg.

Primary location: Melbourne Australia